Life Science

Shaping the future means reinventing yourself today

The life sciences industry is shaping the future — and reinventing itself in the process.

Investor interest, technological advances, and collaborations are driving innovation. But the path to innovation is not without challenges. As they develop medicines, growing biotech companies, medical device firms, and large pharmaceutical companies will face financial risks, regulatory changes, supply chain disruptions, and uncertain return on investment.

To seize new growth opportunities while maintaining stability, life sciences companies need to capitalize on data, optimize performance, manage risk, fund growth, and claim R&D tax credits to drive innovation.

BDO’s Life Sciences Consulting practice offers a comprehensive suite of tax, audit, and advisory services to help clients thrive in this evolving space. Our deep industry expertise makes us a valuable catalyst for our clients’ success. Our team, made up of partners and directors from each Advisory area, brings knowledge tailored to the unique nature of life sciences.

In life sciences, scientific and technological advances create opportunities: attracting investors, leveraging growth potential, and competing advantageously. BDO is ready to help companies innovate and grow in this dynamic sector.

How BDO can help you

Who we Serve

Farma

Laboratories, generics, and specialty pharmaceuticals: M&A, PPA, pricing & market access, compliance.

OTC & Consumer Health

Go-to-market, eCommerce, marketing mix, and demand analytics.

Biotech

Scale-up, financing, partnerships, asset valuation, and regulatory support.

Cosmetics and Beauty

Supply chain optimization, ESG, omnichannel sales, and international expansion.

Healthcare Products

Manufacturers and distributors: quality, traceability, efficiency, and expansion.

CDMOs & CROs

Operations, contracts, data governance, AI, and operational excellence.

Cases Studies

Fertypharm

Fertypharm > Pileje

Advisory to Fertypharm’s shareholders on the sale of 100% of the company to PiLeJe
M&A / Sell side / OTC | Nutracéuticos
Nimgenetics

NIMgenetics > Apposite Capital

Due diligence for Apposite’s entry into the clinical genetics company
Transaction Services / Biotech / Diagnóstico

Contact us

Ignacio Vieira

Ignacio Vieira

Head Healthcare & Life Sciences
View bio
Raúl López

Raúl López

Deal Advisory Partner
View bio

Accelerate your strategic impact in Life Sciences

One team, end-to-end capabilities, agile execution.”

Suscríbete a la Newsletter mensual 
de Healthcare & Life Sciences

Recibe insights, casos, herramientas,novedades del sector y eventos.